Heptares Therapeutics
Simon Poulter has a diverse work experience in the field of scientific research and analysis. Simon currently works at Sosei Heptares, where they started in December 2020 as Principal DMPK Scientist. Prior to this, they held the positions of Senior Scientist II from April 2018 to December 2020, Senior Scientist I from December 2014 to April 2018, and Research Scientist from July 2012 to December 2014.
Before joining Sosei Heptares, Simon worked as a Postdoctoral Research Associate at the University of Cambridge from September 2010 to June 2012. Simon also has experience as an Analytical Chemist at Tickle and Reynolds Public Analyst lab, where they worked from January 2002 to September 2006.
Simon Poulter completed their education in the field of Biochemistry. Simon obtained a Doctor of Philosophy (PhD) degree from the University of Cambridge, where they studied from 2006 to 2010. Prior to that, they earned a Bachelor of Science (BSc) degree in Biochemistry from the University of Exeter, where they attended from 2002 to 2005. In terms of additional certifications, Simon Poulter acquired the Certara Certified NCA Analyst using Phoenix WinNonlin Version 8.0 from Certara in October 2021.
This person is not in any teams
Heptares Therapeutics
Heptares Therapeutics is a drug discovery company focused on novel small-molecule drugs targeting G-protein-coupled receptors (GPCRs), the largest family of druggable targets.The Company has developed a unique, transformational and proprietary technology for making purified, stabilised and functional GPCRs (known as StaRs, StabilisedReceptors), overcoming a major limiting factor to the development of new drugs targeting this group.